Jonathan Graham

Jonathan Graham

General Counsel at AMGEN INC.

Net worth: 14 M $ as of 2026-04-29

65 year
Health Technology
Electronic Technology
Consumer Services

Profile

Jonathan P.
Graham
is currently Director at Nobel Biocare Services AG, Secretary, Executive VP & General Counsel at Amgen, Inc. since 2019, Secretary at Onyx Pharmaceuticals, Inc., and Secretary at ChemoCentryx, Inc. Former positions include Director at Tektronix, Inc. in 2007, Director at Beckman Coulter, Inc., Senior Vice President & General Counsel at Danaher Corp.
from 2006 to 2015, Vice President-Litigation & Legal Policy at GE Aerospace from 2004 to 2006, Secretary, Executive VP & General Counsel at Five Prime Therapeutics, Inc., Partner at Williams & Connolly LLP from 1988 to 2004, and Editor-in-Chief at Texas Law Review.
Education includes graduate studies at The University of Texas at Austin and undergraduate studies at Pitzer College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-06 39,712 ( 0.01% ) 14 M $ 2026-04-29

Jonathan Graham active positions

CompaniesPositionStart
AMGEN INC. General Counsel 2015-07-12
CHEMOCENTRYX, INC. Corporate Secretary -
Director/Board Member -
Corporate Secretary -

Former positions of Jonathan Graham

CompaniesPositionEnd
FIVE PRIME THERAPEUTICS, INC. General Counsel 2021-04-15
DANAHER CORPORATION General Counsel 2015-04-30
Director/Board Member 2007-11-22
GE AEROSPACE General Counsel 2006-05-31
Corporate Officer/Principal 2003-12-31
See the detail of Jonathan Graham's experience

Training of Jonathan Graham

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

81

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Electronic Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Texas Law Review

Health Technology

  1. Stock Market
  2. Insiders
  3. Jonathan Graham